For example, genes such as acyl-CoA synthetase long-chain family member 4 (ACSL4) and GPX4 have been shown to serve as independent predictors of chemosensitivity in neoadjuvant chemotherapy for breast cancer, and their expression levels are strongly associated with patient prognosis (75). This evidence concerns the gene ACSL4 and breast cancer.